rare disease portfolio survival

rare disease portfolio survival

Alexion Rare Disease Data Center Overclaims Survival Gains

Rare disease data centers are essential for accelerating diagnosis and therapy development, yet many assume they are too costly to sustain. In reality, they cut time-to-diagnosis by years and lower research expenses dramatically. This reality emerges from patient registries, AI models, and strategic partnerships across biopharma. Medical Disclaimer: This article